Skip to content
EWEdwards Lifesciences

EW Earnings

Edwards Lifesciences next reports earnings on July 23, 2026. Track record: 3/4 beats.

Next Earnings In

07Days
:
10Hours
:
54Min
:
11Sec

Thursday, July 23, 2026

Current Price

$87.27

EPS Estimate

Earnings Per Share

$0.74

+10.8% YoY

Trailing EPS

Last 12 months earnings

$1.79

Beat Rate

3/4

75%

Forward P/E

Price-to-Earnings ratio

25.9

Margin: 17.4%

Analyst Rating

Buy

26 analysts

Analyst Sentiment

Buy26 analysts
Target: $98.58+13.0%Full analysis →

Earnings History

3/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-03-31$0.73$0.78+7.3%Beat
2025-12-31$0.62$0.58-6.3%Miss
2025-09-30$0.59$0.67+12.6%Beat
2025-06-30$0.62$0.67+7.6%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$0.74+10.8%
Next Qtr(+1q)$0.74+11.2%
Current Year(0y)$3.01+17.5%
Next Year(+1y)$3.37+12.0%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$0.74

Revenue Estimate

$1.7B

Annual EPS Est.

$3.01

+17.5% YoY

EW Earnings FAQ

When is EW's next earnings date?

Edwards Lifesciences (EW) is expected to report earnings on July 23, 2026. The consensus EPS estimate is $0.74.

Does EW usually beat earnings estimates?

Edwards Lifesciences has beaten Wall Street EPS estimates in 3 of the last 4 quarters (75% beat rate).

What is EW's trailing EPS?

Edwards Lifesciences's trailing twelve-month EPS is $1.79. This is calculated from the last four quarters of reported earnings.

What do analysts think about EW?

26 Wall Street analysts cover Edwards Lifesciences. The consensus rating is "Buy" with an average price target of $98.58, implying 13.0% upside from the current price.